Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › EXEL

FARALLON CAPITAL MANAGEMENT, L.L.C. position in EXEL

EXELIXIS INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 13,468,010 shares of EXEL (EXELIXIS INC) in its Q2 2026 13F filing — a position valued at US$732.8M, representing 3.40% of its reported portfolio and ranking #6 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)13.47M sh
Reported value held$732.79M
Portfolio Weight3.40%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s EXEL position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in EXEL in Q3 2023 at 25,860,000 shares (US$565.0M). The position peaked in Q1 2025 at 22,533,500 shares, worth US$831.9M. Across 12 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 13,468,010 shares valued at US$732.8M — an increase of 357,000 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.86M $565.04M New
Q4 2023 26.63M $638.96M Add
Q1 2024 26.68M $633.08M Hold
Q2 2024 27.10M $608.99M Add
Q3 2024 25.41M $659.40M Reduce
Q4 2024 23.44M $780.54M Reduce
Q1 2025 22.53M $831.94M Reduce
Q2 2025 16.04M $706.76M Reduce
Q3 2025 19.50M $805.41M Add
Q4 2025 15.71M $688.55M Reduce
Q1 2026 13.11M $562.33M Reduce
Q2 2026 13.47M $732.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), Renaissance Technologies (US$730.6M), FULLER & THALER ASSET MANAGEMENT, INC. (US$485.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held EXEL?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in EXEL?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 13.47M shares of EXEL (EXELIXIS INC), valued at $732.79M, representing 3.40% of its reported portfolio and ranking #6.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling EXEL?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in EXEL. The position peaked in Q1 2025 at 22.53M shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Farallon Capital Management, Renaissance Technologies, FULLER & THALER ASSET MANAGEMENT, INC., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.